These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2480432)

  • 1. Alpha-fetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorders.
    Gallo V; Cerutti E; Riberi A; Re M; Petrino R; Pecchio F
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):89-93. PubMed ID: 2480432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study on tissue polypeptide antigen (TPA) as a tumor marker].
    Kanauchi M; Sawai F; Saito T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K
    Gan No Rinsho; 1984 Mar; 30(3):265-71. PubMed ID: 6201629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of tissue polypeptide specific antigen as a marker in liver diseases.
    Cetin T; Oğuz A; Algan P; Yildirim IS
    Turk J Gastroenterol; 2003 Sep; 14(3):177-80. PubMed ID: 14655061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-fetoprotein (AFP) in benign liver disease. Evidence that normal liver regeneration does not induce AFP synthesis.
    Alpert E; Feller ER
    Gastroenterology; 1978 May; 74(5 Pt 1):856-8. PubMed ID: 76587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Occurrence of increased alpha-fetoprotein in non-neoplastic hepatopathies of alcoholic or non-alcoholic origin].
    Pol S; Nalpas B; Bezeaud A; Bréchot C; Berthelot P
    Gastroenterol Clin Biol; 1986 Feb; 10(2):112-6. PubMed ID: 2422087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum alpha-fetoprotein in chronic liver disease.
    Weisz G; Udvardy M; Dalmi L; Kulcsár A
    Acta Med Hung; 1983; 40(2-3):155-64. PubMed ID: 6199736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical and biochemical study on tissue polypeptide antigen (TPA) in non-malignant hepatic disorders.
    Collazos J; Genollá J; Ruibal A
    Scand J Clin Lab Invest; 1993 Oct; 53(6):633-7. PubMed ID: 8266011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic histology in chronic liver disease in hepatitis B surface antigen positive cases.
    Ghosh AK; Dasgupta A; Raha K; Jana A; Majumdar DN
    J Indian Med Assoc; 1994 Oct; 92(10):333-5. PubMed ID: 7822848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
    Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma.
    Chen CH; Lin ST; Kuo CL; Nien CK
    Hepatogastroenterology; 2008; 55(85):1423-7. PubMed ID: 18795704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of T and B cells and alpha fetoprotein in hepatic biopsies from patients with liver disease.
    Husby G; Strickland RG; Caldwell JL; Williams RC
    J Clin Invest; 1975 Nov; 56(5):1198-1209. PubMed ID: 52655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alpha fetoprotein in non-neoplastic liver diseases].
    Piantino P; Pecchio F; Gallo V; Giudice L; Bonardi O
    Minerva Med; 1981 May; 72(18):1125-9. PubMed ID: 6164959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine elimination in cirrhotic and non-cirrhotic liver disease of different etiology.
    Joeres R; Brachtel D; Gallenkamp H; Hofstetter G; Klinker H; Zilly W; Richter E
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():56-61. PubMed ID: 7483716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C.
    Bayati N; Silverman AL; Gordon SC
    Am J Gastroenterol; 1998 Dec; 93(12):2452-6. PubMed ID: 9860408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked increase in serum alpha-fetoprotein level in cirrhosis: a case report.
    Sugimoto M; Itsukaichi T; Ishii K; Sumino Y; Sugano S; Abei T; Imamura Y
    Am J Gastroenterol; 1987 Jan; 82(1):69-71. PubMed ID: 2432777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryoglobulinemia in chronic liver diseases.
    Shoenfeld Y; Berliner S; Neeman A; Kadish U; Pinkhas J
    Am J Gastroenterol; 1980 Nov; 74(5):439-40. PubMed ID: 7234822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical value of serum tissue polypeptide specific antigen detection for primary hepatic cancer].
    Huang DR; Zuo Q; Cai HB; Zhang JY; Ji CY
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):89-92. PubMed ID: 15684008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential tumor markers and hepatitis markers profile in liver tumors.
    Khalifa A; Mady EA; Abadeer N; Kamal A
    Anticancer Res; 1999; 19(4A):2495-500. PubMed ID: 10470181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of tumour markers in nasopharyngeal carcinoma.
    Kuo WR; Tsai SM; Jong SB; Juan KH
    J Otolaryngol; 1996 Feb; 25(1):32-6. PubMed ID: 8816107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.